Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors

Details for Australian Patent Application No. 2012201894 (hide)

Owner Incyte Corporation

Inventors Rodgers, James D.; Shepard, Stacey; Maduskuie, Thomas P.; Wang, Haisheng; Falahatpisheh, Nikoo; Rafalski, Maria; Arvanitis, Argyrios G.; Storace, Louis; Jalluri, Ravi Kumar; Fridman, Jordan S.; Vaddi, Krishna

Agent FB Rice

Pub. Number AU-A-2012201894

Parent 2006326548

Filing date 30 March 2012

Wipo publication date 19 April 2012

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

19 April 2012 Application Open to Public Inspection

  Published as AU-A-2012201894

19 April 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012201895-Developing device, image forming apparatus and developer cartridge

2012201893-Container